VB100·2021 China Digital Therapeutics Conference: Call for Top 10 DTx Projects for One-on-One Closed-Door Roadshow
[VB100·2021 China Digital Therapeutics Conference] Postponement Notice
Recently, the COVID-19 epidemic in China has spread to multiple provinces and municipalities, with a significant increase in medium- and high-risk areas across the country, making the epidemic prevention and control situation severe and complex. To further safeguard the health of conference attendees and effectively cooperate with the government in epidemic prevention and control efforts, the event originally scheduled to be held in Binjiang District, Hangzhou, from December 7 to December 8VB100·2021 China Digital Therapeutics ConferencePostponed; the specific date is to be determined and will be announced separately in accordance with government requirements.
We sincerely apologize for any inconvenience caused by the postponement of this conference. We kindly request all attendees to adjust their travel and work schedules accordingly. Thank you for your continued understanding and support!
In the commercialization process of digital therapeutics products, there are many uncertainties arising from innovation.
How to Standardize the Approval and Certification of Digital Therapeutics，How to Establish the Safety and Efficacy of Digital Therapeutics，How to Drive Industrial Innovation and Deliver Patient Benefits Through Medical ProductsThese are the three major challenges that digital therapeutics currently face at the regulatory level. At the same time, digital therapeutics companies also faceUnclear Product Revenue Performance，Business Model Yet to Be Explored，Potentially Fierce CompetitionChallenges such as。
In 2021, to better support entrepreneurs in the digital therapeutics field and enhance their commercialization capabilities, while also building a platform for exchange and collaboration among government, industry, healthcare providers, and investors in the digital therapeutics sector,December 7InHangzhou Sci-Tech Innovation Investment and Trading Center willConveneClosed-Door Roadshow on Digital Therapeutics for Government and Industry Stakeholders. We are now broadly soliciting innovative digital therapeutics projects and interested investment institutions from medical device companies, healthcare service providers, and other enterprises in the digital therapeutics field.
As part of the VB100·2021 China Digital Therapeutics Conference series, this innovative project roadshow will be organized byPeople's Government of Binjiang District, Hangzhou CityGuidance,VCBeat, VB100, VCBeat Research Institute, TigermedHosted by,Hangzhou Binjiang District Bureau of Economy and Information Technology, Zhilan HealthCo-Organizers。
The main agenda of the closed-door negotiation meeting on digital therapeutics among government and industry stakeholders includesInterpretation of Industrial Policies,Corporate Project Pitching and Q&A, One-on-One Partnership Matchmakingetc.Focus on PromotingResource Aggregation: Building a Premier Communication PlatformWe are committed to fostering a conducive development environment by bringing together leading figures in the digital therapeutics industry, as well as professional institutions, enterprises, industry users, and partners from both China and abroad. Our goal is to explore market breakthrough opportunities, share advanced development concepts, and facilitate win-win cooperation among all stakeholders.
Policy Empowerment: The unclear classification of digital therapeutics, coupled with the complex approval and certification processes, presents a common challenge for digital therapeutics companies today. This roadshow plans to invite relevant leaders from the Zhejiang Institute for Medical Device Testing and the Zhejiang Provincial Medical Products Administration to provide policy interpretation and guidance.
Capital Empowerment: After preliminary registration, qualification review, communication and assessment, and other layers of screening, a group of highly qualified investment firms/investors were rigorously selected to participate in the evaluation. A one-on-one exchange and negotiation platform was established to facilitate rapid matching between capital and projects, and to promote the integrated development of technological and capital elements.
Commercial Empowerment:How can solutions with strong application prospects be translated into commercial opportunities? How should registration strategies for digital therapeutics products be formulated? How can regulatory approval be successfully secured? How should risk systems be audited and managed? This event is designed to address these challenges, support the growth of corporate projects, foster collaboration among government, industry, and investors in the innovative field of digital therapeutics, build close partnerships, and accelerate the industrialization of high-quality projects.
Digital therapeutics represent a brand-new beginning. On this path filled with imagination and endless challenges, we warmly invite more “fellow travelers” to join us in exploring the vast and promising frontier of this innovative field.
I. Requirements and Scope of Solicitation
(1) Submission Requirements
1. Comply with national laws, regulations, and industrial policies;
2. Roadshow projects should engage in innovative fields with high growth potentialMedical devices and services related to digital therapeutics, smart terminals, and other projects；
3. The participating project must be an original innovative project, free of any intellectual property disputes, and shall not infringe upon the intellectual property rights, ownership, usage rights, or disposal rights of any third party;
4. Possess a clear technical solution and profit model.
(2) Scope of Call for Submissions
Including but not limited to the following three categories of digital therapeutics product projects:
PreventionA Certain Disease: Such as a Software System for Diabetes Prevention;
ManagementCertain diseases: such as apps that help hypertensive patients manage their blood pressure;
TreatmentSpecific diseases: such as games for treating attention-deficit/hyperactivity disorder (ADHD) in children and apps for treating substance use disorders.
II. Submission Process
Call for Innovative Roadshow Projects: November 9–November 21
Project Communication and Roadshow Guidance: December 1–December 6
Roadshow Materials Preparation: By November 30
Closed-Door Roadshow: December 7
(Scan the QR code to register)
For inquiries, please contact Ms. Lei: 15723032117
(WeChat ID is the same; please add “Roadshow Inquiry” as a note when adding)
VB100·2021 China Digital Therapeutics Conferenceis China's Digital TherapeuticsLargest Industry Scale, Most Up-to-Date Information, Highest Number of High-Quality Enterprises, representing China's digital therapeuticsThe Highest Level of Industrial Developmentannual flagship event. Centered on the two core objectives of comprehensively showcasing the industry’s innovation ecosystem and fully promoting industrial exchange and collaboration, the conference proceeds from three key dimensions—trend analysis, brand empowerment, and partnership matchmaking—to provide a comprehensive analysis of the development trends in the digital therapeutics industry ecosystem. It explores the medical, social, and commercial value across various segmented application scenarios, while bringing together top-tier experts, high-quality enterprises, and premium resources to help cultivate the next decade’s pillar industry hub. (Details:http://nxw.so/68Qm8）
Time: December 7–8, 2021
Location: Binjiang District, Hangzhou
(Limited spots available; register early)
Note: The epidemic prevention and control situation is severe and complex. To effectively cooperate with the government in epidemic prevention and control efforts, the conference has been postponed,The specific date is to be determined., will be announced separately in accordance with government requirements.